Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
548.05
+7.79 (+1.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
76
77
Next >
2 No-Brainer Stocks to Buy Before the End of 2024
↗
December 09, 2024
Via
The Motley Fool
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update
December 08, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
3 No-Brainer Growth Stocks to Buy in December
↗
December 07, 2024
Via
The Motley Fool
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
↗
December 05, 2024
Via
The Motley Fool
FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program
↗
December 04, 2024
CMS launches an outcomes-based model to expand access to FDA-approved gene therapies for sickle cell disease, aiming to improve health outcomes and lower costs.
Via
Benzinga
Looking Into Vertex Pharmaceuticals's Recent Short Interest
↗
November 25, 2024
Via
Benzinga
Got $500? 1 Biotech Stock to Buy and Hold Forever
↗
November 22, 2024
Via
The Motley Fool
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
↗
November 18, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
December 04, 2024
Via
Benzinga
It’s Been A Tough Month For Healthcare Stocks
↗
December 02, 2024
It’s been a very difficult month for the healthcare sector not only because of disappointing company news but also disruption caused by the election and future policy issues.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
↗
November 28, 2024
Via
The Motley Fool
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
↗
November 24, 2024
Via
The Motley Fool
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
↗
November 18, 2024
Via
The Motley Fool
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
↗
November 05, 2024
Via
Benzinga
Assessing Vertex Pharmaceuticals: Insights From 11 Financial Analysts
↗
November 05, 2024
Via
Benzinga
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
↗
November 16, 2024
Via
The Motley Fool
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity
↗
November 13, 2024
Regulators are reviewing what could become a multi-billion-dollar drug.
Via
The Motley Fool
Biotech Stocks Are Rallying: What Is Your Playbook?
↗
November 11, 2024
If you have been reading our posts you know that some of the big biotech winners have taken a hit after earnings : LLY, MRK and REGN. But ABBV, GILD, LLY, and VRTX remain among the top performers.
Via
Talk Markets
Five S&P 500 Stocks, All Elite IBD Giants, Near Buy Points
↗
November 09, 2024
Meta just forged a new base. All five stocks are on the IBD Leaderboard list.
Via
Investor's Business Daily
Topics
Stocks
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
↗
November 08, 2024
A Fed rate cut and a slew of big earnings reports filled out a busy week.
Via
Investor's Business Daily
Topics
Economy
Government
2 Biotech Stocks You Can Buy Hand Over Fist This Month
↗
November 08, 2024
Both stocks have made significant breakthroughs.
Via
The Motley Fool
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
↗
November 05, 2024
Wall Street rallied on Tuesday as improved investor sentiment aligned with millions of Americans casting their votes for the 47th president.
Via
Benzinga
5 Top Stocks to Buy in November
↗
November 05, 2024
From blue chip dividend stocks to industry-leading growth stocks, there are plenty of bargains in today's market if you know where to look.
Via
The Motley Fool
My 2 Favorite Growth Stocks to Buy Hand Over Fist in November
↗
November 05, 2024
The sky's the limit for these stocks.
Via
The Motley Fool
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript
↗
November 04, 2024
VRTX earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms
↗
November 04, 2024
Vertex Pharmaceuticals beat third-quarter expectations on Monday. The company also raised its sales outlook.
Via
Investor's Business Daily
Vertex Reports Third Quarter 2024 Financial Results
November 04, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required
↗
November 04, 2024
A bit of earnings and election jitters roiled the market last week reordering the leaderboard in biopharma stocks.
Via
Talk Markets
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
↗
November 04, 2024
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday.
Via
Benzinga
Jim Cramer Says Vertex Doing 'Lord's Work': Can Q3 Earnings Outshine Bearish Charts?
↗
November 04, 2024
VRTX to report Q3 earnings, expected EPS $4.14 and $2.72B in revenue. Cramer calls it a buy, analysts see 22% upside. Stock faces bearish trend.
Via
Benzinga
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
76
77
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
